These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9290894)

  • 1. Pharmacy-managed program for home treatment of deep vein thrombosis with enoxaparin.
    Dedden P; Chang B; Nagel D
    Am J Health Syst Pharm; 1997 Sep; 54(17):1968-72. PubMed ID: 9290894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of home treatment of deep vein thrombosis with subcutaneous once-daily enoxaparin plus warfarin.
    Bishop B; Wilson AG; Post D; Howard L; Ruehlen L
    J Manag Care Pharm; 2006; 12(1):70-5. PubMed ID: 16420110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgery.
    Hawkins DW; Langley PC; Krueger KP
    Clin Ther; 1998; 20(1):182-95. PubMed ID: 9522114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin.
    Spyropoulos AC; Hurley JS; Ciesla GN; de Lissovoy G
    Chest; 2002 Jul; 122(1):108-14. PubMed ID: 12114345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
    Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
    Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization.
    Tillman DJ; Charland SL; Witt DM
    Arch Intern Med; 2000 Oct; 160(19):2926-32. PubMed ID: 11041899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High doses of warfarin are more beneficial than its low doses in patients with deep vein thrombosis.
    Farahmand S; Saeedi M; Seyed Javadi HH; Khashayar P
    Am J Emerg Med; 2011 Nov; 29(9):1222-6. PubMed ID: 21035980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial.
    Suchkov IA; Martinez-Gonzalez J; Schellong SM; Garbade T; Falciani M;
    Clin Drug Investig; 2018 Feb; 38(2):181-189. PubMed ID: 29214507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improving recanalization of deep veins and the "outcomes" of venous thromboembolic complications in prolonged therapy with enoxaparin].
    Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Kirienko AI
    Angiol Sosud Khir; 2010; 17(1):87-94. PubMed ID: 21780625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
    Kucher N; Quiroz R; McKean S; Sasahara AA; Goldhaber SZ
    Vasc Med; 2005 Nov; 10(4):251-6. PubMed ID: 16444853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.
    Garcia-Zozaya I
    J Ky Med Assoc; 1998 Apr; 96(4):143-8. PubMed ID: 9577110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
    Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
    Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins].
    Vorob'eva NM; Panchenko EP; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Khasanova ZB; Postnov AIu; Kirienko AI
    Ter Arkh; 2011; 83(8):33-7. PubMed ID: 21961329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dalteparin for deep venous thrombosis: a hospital-in-the-home program.
    Ting SB; Ziegenbein RW; Gan TE; Catalano JV; Monagle P; Silvers J; Chambers FE; Ng S; McGrath BP
    Med J Aust; 1998 Mar; 168(6):272-6. PubMed ID: 9549534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out-patient treatment of acute deep vein thrombosis.
    Mattiasson I; Berntorp E; Bornhov S; Lagerstedt C; Lethagen S; Persson J; Timberg I; Torstensson I
    Int Angiol; 1998 Sep; 17(3):146-50. PubMed ID: 9821026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin.
    Smith BJ; Weekley JS; Pilotto L; Howe T; Beven R
    Intern Med J; 2002; 32(1-2):29-34. PubMed ID: 11783670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic model of enoxaparin versus heparin for prevention of deep vein thrombosis after total hip replacement.
    Hawkins DW; Langley PC; Krueger KP
    Am J Health Syst Pharm; 1997 May; 54(10):1185-90. PubMed ID: 9161627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.